Literature DB >> 31558674

The microRNA miR-196b acts as a tumor suppressor in Cdx2-driven acute myeloid leukemia.

Vijay P S Rawat1, Maria Götze2, Avinash Rasalkar2, Naidu M Vegi2, Susann Ihme2, Silvia Thoene3, Alessandro Pastore4, Deepak Bararia4, Hartmut Döhner5, Konstanze Döhner5, Michaela Feuring-Buske2,5, Leticia Quintanilla-Fend6, Christian Buske7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31558674      PMCID： PMC7271585          DOI： 10.3324/haematol.2019.223297

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  15 in total

1.  miR-196b inhibits cell migration and invasion through targeting MAP3K1 in hydatidiform mole.

Authors:  Zhenzhen Guo; Linlin Sui; Jia Qi; Qiannan Sun; Yuefei Xu; Na Zou; Yunpeng Xie; Ying Kong
Journal:  Biomed Pharmacother       Date:  2019-03-16       Impact factor: 6.529

2.  Potential tumor suppressive function of miR-196b in B-cell lineage acute lymphoblastic leukemia.

Authors:  Suman Bhatia; Deepak Kaul; Neelam Varma
Journal:  Mol Cell Biochem       Date:  2010-02-21       Impact factor: 3.396

3.  Stem cell gene expression programs influence clinical outcome in human leukemia.

Authors:  Kolja Eppert; Katsuto Takenaka; Eric R Lechman; Levi Waldron; Björn Nilsson; Peter van Galen; Klaus H Metzeler; Armando Poeppl; Vicki Ling; Joseph Beyene; Angelo J Canty; Jayne S Danska; Stefan K Bohlander; Christian Buske; Mark D Minden; Todd R Golub; Igor Jurisica; Benjamin L Ebert; John E Dick
Journal:  Nat Med       Date:  2011-08-28       Impact factor: 53.440

4.  Regulation of mir-196b by MLL and its overexpression by MLL fusions contributes to immortalization.

Authors:  Relja Popovic; Laurie E Riesbeck; Chinavenmeni S Velu; Aditya Chaubey; Jiwang Zhang; Nicholas J Achille; Frank E Erfurth; Katherine Eaton; Jun Lu; H Leighton Grimes; Jianjun Chen; Janet D Rowley; Nancy J Zeleznik-Le
Journal:  Blood       Date:  2009-02-02       Impact factor: 22.113

5.  Overexpression of CDX2 perturbs HOX gene expression in murine progenitors depending on its N-terminal domain and is closely correlated with deregulated HOX gene expression in human acute myeloid leukemia.

Authors:  Vijay P S Rawat; Silvia Thoene; Vegi M Naidu; Natalia Arseni; Bernhard Heilmeier; Klaus Metzeler; Konstantin Petropoulos; Aniruddha Deshpande; Leticia Quintanilla-Martinez; Stefan K Bohlander; Karsten Spiekermann; Wolfgang Hiddemann; Michaela Feuring-Buske; Christian Buske
Journal:  Blood       Date:  2007-09-12       Impact factor: 22.113

6.  Ectopic expression of the homeobox gene Cdx2 is the transforming event in a mouse model of t(12;13)(p13;q12) acute myeloid leukemia.

Authors:  Vijay P S Rawat; Monica Cusan; Aniruddha Deshpande; Wolfgang Hiddemann; Leticia Quintanilla-Martinez; R Keith Humphries; Stefan K Bohlander; Michaela Feuring-Buske; Christian Buske
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-12       Impact factor: 11.205

7.  miR-196b directly targets both HOXA9/MEIS1 oncogenes and FAS tumour suppressor in MLL-rearranged leukaemia.

Authors:  Zejuan Li; Hao Huang; Ping Chen; Miao He; Yuanyuan Li; Stephen Arnovitz; Xi Jiang; Chunjiang He; Elizabeth Hyjek; Jun Zhang; Zhiyu Zhang; Abdel Elkahloun; Donglin Cao; Chen Shen; Mark Wunderlich; Yungui Wang; Mary Beth Neilly; Jie Jin; Minjie Wei; Jun Lu; Peter J M Valk; Ruud Delwel; Bob Lowenberg; Michelle M Le Beau; James Vardiman; James C Mulloy; Nancy J Zeleznik-Le; Paul P Liu; Jiwang Zhang; Jianjun Chen
Journal:  Nat Commun       Date:  2012-02-21       Impact factor: 14.919

8.  The homeobox gene CDX2 is aberrantly expressed in most cases of acute myeloid leukemia and promotes leukemogenesis.

Authors:  Claudia Scholl; Dimple Bansal; Konstanze Döhner; Karina Eiwen; Brian J P Huntly; Benjamin H Lee; Frank G Rücker; Richard F Schlenk; Lars Bullinger; Hartmut Döhner; D Gary Gilliland; Stefan Fröhling
Journal:  J Clin Invest       Date:  2007-03-08       Impact factor: 14.808

9.  The transcriptional architecture of early human hematopoiesis identifies multilevel control of lymphoid commitment.

Authors:  Elisa Laurenti; Sergei Doulatov; Sasan Zandi; Ian Plumb; Jing Chen; Craig April; Jian-Bing Fan; John E Dick
Journal:  Nat Immunol       Date:  2013-05-26       Impact factor: 25.606

10.  miR-196b target screen reveals mechanisms maintaining leukemia stemness with therapeutic potential.

Authors:  Sara E Meyer; David E Muench; Andrew M Rogers; Tess J Newkold; Emily Orr; Eric O'Brien; John P Perentesis; John G Doench; Ashish Lal; Patrick J Morris; Craig J Thomas; Judy Lieberman; Edwina McGlinn; Bruce J Aronow; Nathan Salomonis; H Leighton Grimes
Journal:  J Exp Med       Date:  2018-07-11       Impact factor: 14.307
View more
  3 in total

Review 1.  Mesenchymal stromal cell-derived extracellular vesicles: novel approach in hematopoietic stem cell transplantation.

Authors:  Davod Pashoutan Sarvar; Hosein Effatpanah; Parvin Akbarzadehlaleh; Karim Shamsasenjan
Journal:  Stem Cell Res Ther       Date:  2022-05-16       Impact factor: 8.079

2.  A pan-cancer atlas of somatic mutations in miRNA biogenesis genes.

Authors:  Paulina Galka-Marciniak; Martyna Olga Urbanek-Trzeciak; Paulina Maria Nawrocka; Piotr Kozlowski
Journal:  Nucleic Acids Res       Date:  2021-01-25       Impact factor: 16.971

3.  Oncogenic Role of miR-217 During Clear Cell Renal Carcinoma Progression.

Authors:  Jose María Zamora-Fuentes; Enrique Hernández-Lemus; Jesús Espinal-Enríquez
Journal:  Front Oncol       Date:  2022-07-22       Impact factor: 5.738
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.